In patients with COVID-19, high levels of cystatin C independently predict the risk of developing a more serious disease and adverse outcome [13], which is in agreement with findings in unselected intensive care unit (ICU) patients, where the cystatin C-based equation predicted mortality better than a creatinine-based equation [14]. Here, CST3 is linked to COVID-19.